About us - PM Group
The future of patient specific medicine, including cell and gene therapy, is driving a need for flexible facility designs to ship product fast.
Cell and Gene Therapy manufacturing facility of the future
This is enabled by extensive automation, data transparency, and real time release, with autonomous robotics facilitating high product throughput and environmental monitoring.
The CGT facility will incorporate an automated warehouse, facilitating rapid deployment of personalised treatments to the clinic for patient use.
Talk to our team to find out how we can assist in the development of CGT and ATMP facilities.